ACROX | CARYX | ACROX / CARYX | |
Total Expense Ratio | 1.26 | 0.77 | 164% |
Annual Report Gross Expense Ratio | 1.47 | 0.77 | 191% |
Fund Existence | 11 years | 11 years | - |
Gain YTD | 15.906 | 12.748 | 125% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 1000000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 96.9M | 2.5B | 4% |
Annual Yield % from dividends | 1.19 | 2.28 | 52% |
Returns for 1 year | 7.90 | 10.33 | 76% |
Returns for 3 years | 66.69 | 34.93 | 191% |
Returns for 5 years | 95.96 | 11.68 | 822% |
Returns for 10 years | 109.86 | 37.19 | 295% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DTCYX | 21.47 | 0.11 | +0.51% |
BNY Mellon Sust US Equity Y | |||
FTRIX | 30.29 | 0.13 | +0.43% |
Fidelity Advisor Mega Cap Stock I | |||
PREFX | 86.41 | 0.29 | +0.34% |
T. Rowe Price Tax-Efficient Equity | |||
MSVOX | 6.25 | -0.01 | -0.16% |
Morgan Stanley Vitality Portfolio R6 | |||
ASCQX | 17.38 | -0.04 | -0.23% |
American Century Small Company I |